|
Apr 30
|
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
|
|
Apr 30
|
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
|
|
Apr 30
|
Lilly counts on manufacturing scale-up to unstick obesity drug supply
|
|
Apr 30
|
Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound
|
|
Apr 29
|
Why these analysts are bullish on healthcare stocks
|
|
Apr 29
|
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
|
|
Apr 29
|
Should You Invest in Novo Nordisk (NVO) Ahead of Q1 Earnings?
|
|
Apr 29
|
UPDATE 2-One dose of Novo Nordisk's Wegovy back in supply, FDA website shows
|
|
Apr 29
|
Novo Nordisk: Growth Is Still A Better Choice
|
|
Apr 29
|
Billionaire Investor Jim Simons Just Bought These 3 "Magnificent Seven" Stocks
|
|
Apr 28
|
Is Viking Therapeutics Incredibly Undervalued?
|
|
Apr 27
|
Forget Nvidia, These Unstoppable Stocks Are Better Buys
|
|
Apr 27
|
1 Unstoppable Pharmaceutical Stock Investors Shouldn't Sleep On
|
|
Apr 26
|
Dow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom
|
|
Apr 26
|
Stocks to watch next week: Amazon, Apple, Anglo American and Novo Nordisk
|
|
Apr 26
|
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
|
|
Apr 25
|
Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
|
|
Apr 25
|
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
|
|
Apr 24
|
Novo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why
|
|
Apr 24
|
Sector Update: Health Care Stocks Slipping Late Afternoon
|